E-LIB Suche - Ergebnisse für: Alborn, William E.

1

Comparison of Protein Immunoprecipitation-Multiple Reaction..:

Lin, De ; Alborn, William E. ; Slebos, Robbert J. C..
Journal of Proteome Research. 12 (2013) 12 - p. 5996-6003 , 2013

Link: https://doi.org/10.1021/..

2

Development of a Novel Sandwich ELISA for Measuring Cell Ly..:

Troutt, Jason S. ; Alborn, William E. ; Bellinger, Melissa A....
Lipids. 45 (2010) 8 - p. 757-764 , 2010

Link: https://doi.org/10.1007/..

3

Fenofibrate treatment increases human serum proprotein conv..:

Troutt, Jason S. ; Alborn, William E. ; Cao, Guoqing.
Journal of Lipid Research. 51 (2010) 2 - p. 345-351 , 2010

Link: https://doi.org/10.1194/..

4

Atorvastatin increases human serum levels of proprotein con..:

Careskey, Holly E. ; Davis, R. Aleks ; Alborn, William E....
Journal of Lipid Research. 49 (2008) 2 - p. 394-398 , 2008

Link: https://doi.org/10.1194/..

5

The development of methodology for clinical measurement of ..:

Willey, Mark B. ; Alborn, William E. ; Lutzke, Barry S....
Journal of Pharmaceutical and Biomedical Analysis. 48 (2008) 5 - p. 1397-1403 , 2008

Link: https://doi.org/10.1016/..

6

An apolipoprotein A-I mimetic dose-dependently increases th..:

Troutt, Jason S. ; Alborn, William E. ; Mosior, Marian K....
Journal of Lipid Research. 49 (2008) 3 - p. 581-587 , 2008

Link: https://doi.org/10.1194/..

7

Secreted proprotein convertase subtilisin/kexin type 9 redu..:

Schmidt, Robert J. ; Beyer, Thomas P. ; Bensch, William R....
Biochemical and Biophysical Research Communications. 370 (2008) 4 - p. 634-640 , 2008

Link: https://doi.org/10.1016/..

8

Relationship of apolipoprotein A5 and apolipoprotein C3 lev..:

Alborn, William E. ; Prince, Melvin J. ; Konrad, Robert J.
Clinica Chimica Acta. 378 (2007) 1-2 - p. 154-158 , 2007

Link: https://doi.org/10.1016/..

9

Serum Proprotein Convertase Subtilisin Kexin Type 9 Is Corr..:

Konrad, Robert J ; Conner, Elaine M ; Davies, Julian...
Clinical Chemistry. 53 (2007) 10 - p. 1814-1819 , 2007

Link: https://doi.org/10.1373/..

10

Analytical Validation and Biological Evaluation of a High–M..:

Mistry, Jehangir S ; Scherer, Philipp E ; Konrad, Robert J...
Clinical Chemistry. 53 (2007) 12 - p. 2144-2151 , 2007

Link: https://doi.org/10.1373/..

11

Alloxan is an inhibitor of O-GlcNAc-selective N-acetyl-β-d-..:

Lee, Thomas N. ; Alborn, William E. ; Knierman, Michael D..
Biochemical and Biophysical Research Communications. 350 (2006) 4 - p. 1038-1043 , 2006

Link: https://doi.org/10.1016/..

12

Definitive N-Terminal Protein Sequence and Further Characte..:

Konrad, Robert J ; Prince, Melvin J ; Johnson, Melvin G.
Clinical Chemistry. 52 (2006) 3 - p. 514-517 , 2006

Link: https://doi.org/10.1373/..

13

The diabetogenic antibiotic streptozotocin modifies the try..:

Lee, Thomas N. ; Alborn, William E. ; Knierman, Michael D..
Biochemical Pharmacology. 72 (2006) 6 - p. 710-718 , 2006

Link: https://doi.org/10.1016/..

14

The Novel Apolipoprotein A5 Is Present in Human Serum, Is A..:

Konrad, Robert J ; Schultze, Albert E ; Knierman, Michael D...
Clinical Chemistry. 51 (2005) 2 - p. 351-359 , 2005

Link: https://doi.org/10.1373/..

15

Administration of a PPARα agonist increases serum apolipopr..:

Schultze, Albert E. ; Alborn, William E. ; Newton, Ronald K..
Journal of Lipid Research. 46 (2005) 8 - p. 1591-1595 , 2005

Link: https://doi.org/10.1194/..